News

The two products in Xolegel CorePak are new Xebcort gel, a 1% hydrocortisone gel, and Xolegel (ketoconazole, USP) gel, 2%. Xebcort gel provides quick symptom relief and is

The approval was based on two international Phase III double-blind, placebo-controlled trials that evaluated more than 800 patients who received no prior systemic therapy. Nexavar targets both the

The agreement also includes the provision for final interpretations of Singapore radiological studies upon validation by the Singapore Ministry of Health. Sean Casey, CEO of Virtual Radiologic, said:

GlaxoSmithKline’s (GSK’s) investment is expected to support research at Harvard University and in at least four Harvard-affiliated hospitals in the areas of neuroscience, heart disease, cancer, diabetes, musculoskeletal

Mr Hunt will report directly to Randal Mills, president and CEO. Additionally, Philip Jacoby, Jr, the company’s controller and interim CFO, has been promoted to the position of

The Phase II double-blinded, randomized, placebo-controlled study will assess cobiprostone’s safety and efficacy in treating portal hypertension. The study plans to enroll approximately 30 patients at the University

The approval enables CompuMed to sell the OsteoGram product as an approved clinical device in China and will allow CompuMed to work with its Chinese original equipment manufacturers

Ranbaxy’s Omeprazole 40mg is indicated for the treatment of acid-related disease, including gastric ulcer and Zollinger-Ellison syndrome. Jim Meehan, vice president of sales and distribution at Ranbaxy Pharmaceuticals,

New Medical Imaging’s (NMI) Gemini flat panels are easily integrated into Del’s tables, which allows existing customers to upgrade or field retrofit their digital imaging systems. All of